Overview
Probe's complete MicroEye® system is available for licensing, trial or demonstration now.
- Enables continuous, online and automated monitoring of substances in circulating blood without withdrawing blood from the patient
- Can provide real-time information
- Inserted using common peripheral venous catheters
- Easy to use and reduces risk of contact with blood borne pathogens
- Produces a 'plasma-like' sample without the need for blood centrifugation
- Samples can be collected for off-line analysis if required.
Having successfully completed the CE marking, the MicroEye® is now available for use in Europe.
The MicroEye® is intended for intravenous use for periods of up to 48 hours and is inserted via an 18G blood catheter.
The range of substances that can be monitored using the MicroEye® is vast including:
- Electrolytes (potassium, magnesium etc.)
- Energy metabolites (glucose, lactate, pyruvate, etc.)
- Amino acids (glutamate, GABA, etc.)
- Hormones and neurotransmitters (dopamine, serotonin (5-HT) etc.)
- Inflammatory mediators and growth factors (cytokines, etc.)
- Drugs and their metabolites (unbound ‘free’).
See applications and markets >>
Route of Access
Probe's MicroEye® device has been designed and developed from the beginning with safety in mind. It carries the CE marking for sale in Europe and Probe Scientific hold Certification Standards: Directive 93/42/EEC, ISO 13485:2003 - Medical Device Certification, from a Notified Body appointed by a Competent Authority.
Need more information or advice?
For further technical information or advice on using the MicroEye® please complete our contact form.
This product is not currently available in the USA.